Bloor K, Maynard A, Freemantle N
Department of Health Sciences and Clinical Evaluation, University of York.
BMJ. 1996 Jul 6;313(7048):33-5. doi: 10.1136/bmj.313.7048.33.
This is the third of three papers that review international policies to control spending on drugs and to improve the efficiency of drug use. This paper reviews policies regulating the supply of drugs, particularly licensing and reimbursement controls, price and profit regulation. Price and profit controls contain few incentives for improving cost effective use of drugs, and focus on cost containment and profitability of domestic industry. Carefully monitored economic evaluation could lead to improvements in efficiency and benefits to patients and the health care system.
这是三篇系列论文中的第三篇，该系列论文回顾了控制药品支出及提高药品使用效率的国际政策。本文回顾了规范药品供应的政策，尤其是许可和报销控制、价格及利润监管。价格和利润控制对提高药品成本效益使用的激励甚少，且侧重于成本控制和国内产业的盈利能力。经过审慎监测的经济评估能够提高效率，并使患者和医疗保健系统受益。
